- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISBN
-
9783540195436
3540195432
9780387195438
0387195432
- Maße
-
28 cm
- Umfang
-
VIII, 168 S.
- Sprache
-
Englisch
- Anmerkungen
-
Ill., graph. Darst.
Literaturangaben
- Schlagwort
-
Neuroblastom
MIBG-Szintigraphie
Neuroblastom
Neuroblastom
- Ereignis
-
Veröffentlichung
- (wo)
-
London, Berlin, Heidelberg, New York, Paris, Tokyo
- (wer)
-
Springer
- (wann)
-
1989
- Urheber
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Moyes, Judy
- McCready, V. R.
- Fullbrook, Ann
- Springer
Entstanden
- 1989
Ähnliche Objekte (12)
Thrombocytopenia after meta-iodobenzylguanidine (MIBG) therapy in neuroblastoma patients may be caused by selective MIBG uptake via the serotonin transporter located on megakaryocytes
123I metaiodobenzylguanidine (MIBG) uptake predicts early relapse of neuroblastoma using semi-quantitative SPECT/CT analysis
Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptake
Analysis of quantitative [I-123] mIBG SPECT/CT in a phantom and in patients with neuroblastoma
123I-mIBG scintigraphy in neuroblastoma: development of a SIOPEN semi-quantitative reporting ,method by an international panel
Improved Synthesis of No-Carrier-Added [*I]MIBG and Its Precursor
Aurora Kinase A inhibition enhances DNA damage and tumor cell death with 131I-MIBG therapy in high-risk neuroblastoma
Using systematic reviews to identify research gaps - a case study: mIBG for the treatment of neuroblastoma in children
Differential diagnosis of parkinsonism: a head-to-head comparison of FDG PET and MIBG scintigraphy
Differential diagnosis of parkinsonism: a head-to-head comparison of FDG PET and MIBG scintigraphy
Differential diagnosis of parkinsonism: a head-to-head comparison of FDG PET and MIBG scintigraphy
Impact of mediastinal, liver and lung 123I-metaiodobenzylguanidine (123I-MIBG) washout on calculated 123I-MIBG myocardial washout
Thrombocytopenia after meta-iodobenzylguanidine (MIBG) therapy in neuroblastoma patients may be caused by selective MIBG uptake via the serotonin transporter located on megakaryocytes
123I metaiodobenzylguanidine (MIBG) uptake predicts early relapse of neuroblastoma using semi-quantitative SPECT/CT analysis
Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptake
Analysis of quantitative [I-123] mIBG SPECT/CT in a phantom and in patients with neuroblastoma
123I-mIBG scintigraphy in neuroblastoma: development of a SIOPEN semi-quantitative reporting ,method by an international panel
Improved Synthesis of No-Carrier-Added [*I]MIBG and Its Precursor
Aurora Kinase A inhibition enhances DNA damage and tumor cell death with 131I-MIBG therapy in high-risk neuroblastoma
Using systematic reviews to identify research gaps - a case study: mIBG for the treatment of neuroblastoma in children
Differential diagnosis of parkinsonism: a head-to-head comparison of FDG PET and MIBG scintigraphy
Differential diagnosis of parkinsonism: a head-to-head comparison of FDG PET and MIBG scintigraphy
Differential diagnosis of parkinsonism: a head-to-head comparison of FDG PET and MIBG scintigraphy
Impact of mediastinal, liver and lung 123I-metaiodobenzylguanidine (123I-MIBG) washout on calculated 123I-MIBG myocardial washout
Thrombocytopenia after meta-iodobenzylguanidine (MIBG) therapy in neuroblastoma patients may be caused by selective MIBG uptake via the serotonin transporter located on megakaryocytes
123I metaiodobenzylguanidine (MIBG) uptake predicts early relapse of neuroblastoma using semi-quantitative SPECT/CT analysis
Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptake
Analysis of quantitative [I-123] mIBG SPECT/CT in a phantom and in patients with neuroblastoma
123I-mIBG scintigraphy in neuroblastoma: development of a SIOPEN semi-quantitative reporting ,method by an international panel
Improved Synthesis of No-Carrier-Added [*I]MIBG and Its Precursor
Aurora Kinase A inhibition enhances DNA damage and tumor cell death with 131I-MIBG therapy in high-risk neuroblastoma
Using systematic reviews to identify research gaps - a case study: mIBG for the treatment of neuroblastoma in children
Differential diagnosis of parkinsonism: a head-to-head comparison of FDG PET and MIBG scintigraphy
Differential diagnosis of parkinsonism: a head-to-head comparison of FDG PET and MIBG scintigraphy
Differential diagnosis of parkinsonism: a head-to-head comparison of FDG PET and MIBG scintigraphy